UY28366A1 - Compuestos químicos - Google Patents

Compuestos químicos

Info

Publication number
UY28366A1
UY28366A1 UY28366A UY28366A UY28366A1 UY 28366 A1 UY28366 A1 UY 28366A1 UY 28366 A UY28366 A UY 28366A UY 28366 A UY28366 A UY 28366A UY 28366 A1 UY28366 A1 UY 28366A1
Authority
UY
Uruguay
Prior art keywords
chemical compounds
preparation
treatment
proliferative diseases
medicaments
Prior art date
Application number
UY28366A
Other languages
English (en)
Inventor
Andrew Mortlock
Nicola Heron
Frederic Jung
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33522456&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY28366(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of UY28366A1 publication Critical patent/UY28366A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Derivados de quinazolina de fórmula (i): para uso en el tratamiento de enfermedades proliferativas tales como cáncer y en la preparación de medicamentos para uso en el tratamiento de enfermedades proliferativas y procesos para su preparación, así como de composiciones farmacéuticas que los contienen como ingredientes activo.
UY28366A 2003-06-17 2004-06-17 Compuestos químicos UY28366A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03291463 2003-06-17

Publications (1)

Publication Number Publication Date
UY28366A1 true UY28366A1 (es) 2005-01-31

Family

ID=33522456

Family Applications (1)

Application Number Title Priority Date Filing Date
UY28366A UY28366A1 (es) 2003-06-17 2004-06-17 Compuestos químicos

Country Status (16)

Country Link
US (1) US20060178382A1 (es)
EP (1) EP1644361A1 (es)
JP (1) JP2006527748A (es)
KR (1) KR20060011891A (es)
CN (1) CN1835945A (es)
AR (1) AR045694A1 (es)
AU (1) AU2004249477A1 (es)
BR (1) BRPI0411503A (es)
CA (1) CA2529250A1 (es)
IL (1) IL172375A0 (es)
MX (1) MXPA05013825A (es)
NO (1) NO20055891L (es)
TW (1) TW200505452A (es)
UY (1) UY28366A1 (es)
WO (1) WO2004113324A1 (es)
ZA (1) ZA200510257B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2005135337A (ru) * 2003-04-16 2006-06-10 Астразенека Аб (Se) Производные хиназолина для лечения злокачественного новообразования
DE602004015108D1 (de) * 2003-06-02 2008-08-28 Astrazeneca Ab (3-((chinazolin-4-yl)amino)-1h-pyrazol-1-yl)acetamid derivate und verwandte verbindungen als aurora kinase inhibitoren zur behandlung von proliferativen erkrankungen wie krebs
JP4237242B2 (ja) * 2004-10-12 2009-03-11 アストラゼネカ アクチボラグ キナゾリン誘導体
US7713973B2 (en) 2004-10-15 2010-05-11 Takeda Pharmaceutical Company Limited Kinase inhibitors
DE602006004976D1 (de) * 2005-03-28 2009-03-12 Bristol Myers Squibb Co Kompetitive atp-kinasehemmer
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
JP2009528335A (ja) * 2006-03-02 2009-08-06 アストラゼネカ アクチボラグ キナゾリン誘導体
UY30183A1 (es) 2006-03-02 2007-10-31 Astrazeneca Ab Derivados de quinolina
CA2652634A1 (en) * 2006-05-18 2007-11-29 Amphora Discovery Corporation Certain substituted quinolones, compositions, and uses thereof
GB0619342D0 (en) * 2006-09-30 2006-11-08 Vernalis R&D Ltd New chemical compounds
US20100120717A1 (en) 2006-10-09 2010-05-13 Brown Jason W Kinase inhibitors
WO2009114703A2 (en) * 2008-03-12 2009-09-17 Fox Chase Cancer Center Combination therapy for the treatment of cancer
BR112019022229A2 (pt) * 2017-04-27 2020-05-12 Astrazeneca Ab Compostos de anilinoquinazolina c5 e seu uso no tratamento do câncer
ES2887261T3 (es) * 2017-04-27 2021-12-22 Astrazeneca Ab Compuestos de fenoxiquinazolina y su uso para tratar el cáncer
KR20190043842A (ko) 2017-10-19 2019-04-29 건국대학교 산학협력단 피리미딘-2-아민 유도체, 이의 제조방법 및 이를 포함하는 항암제
CN110372666B (zh) * 2018-04-13 2022-11-08 华东理工大学 喹唑啉类化合物作为egfr三突变抑制剂及其应用
EP3927330A4 (en) * 2019-02-19 2022-11-30 The Regents of the University of California NURR1 RECEPTOR MODULATORS
KR102061458B1 (ko) 2019-08-14 2019-12-31 건국대학교 산학협력단 피리미딘-2-아민 유도체, 이의 제조방법 및 이를 포함하는 항암제
CN112939948B (zh) * 2019-12-11 2022-05-17 苏州美诺医药科技有限公司 新型含喹唑啉类化合物及其中间体与应用
CN113200964B (zh) * 2021-04-25 2022-07-05 南方医科大学南方医院 18f标记的egfr正电子显像剂及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9922171D0 (en) * 1999-09-21 1999-11-17 Zeneca Ltd Chemical compounds
PL360439A1 (en) * 2000-06-28 2004-09-06 Astrazeneca Ab Substituted quinazoline derivatives and their use as inhibitors
AU2002350105A1 (en) * 2001-06-21 2003-01-08 Ariad Pharmaceuticals, Inc. Novel quinazolines and uses thereof
ATE446093T1 (de) * 2001-12-24 2009-11-15 Astrazeneca Ab Substituierte chinazolin-derivate als aurora- kinase inhibitoren

Also Published As

Publication number Publication date
CN1835945A (zh) 2006-09-20
WO2004113324A1 (en) 2004-12-29
AU2004249477A1 (en) 2004-12-29
CA2529250A1 (en) 2004-12-29
NO20055891L (no) 2006-02-07
US20060178382A1 (en) 2006-08-10
BRPI0411503A (pt) 2006-07-25
MXPA05013825A (es) 2006-02-28
JP2006527748A (ja) 2006-12-07
ZA200510257B (en) 2007-05-30
TW200505452A (en) 2005-02-16
AR045694A1 (es) 2005-11-09
KR20060011891A (ko) 2006-02-03
IL172375A0 (en) 2009-02-11
EP1644361A1 (en) 2006-04-12

Similar Documents

Publication Publication Date Title
UY28271A1 (es) Compuestos químicos
UY28366A1 (es) Compuestos químicos
UY28510A1 (es) Compuestos quimicos
UY30759A1 (es) Compuestos quimicos
UY29562A1 (es) Compuestos heterocíclicos de amino benzoilo, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones
ECSP109935A (es) Derivados de morfolino pirimidina utilizados en enfermedades relacionadas con mtor quinasa y/o pi3k
AR047928A1 (es) Derivados de tetrahidropiridoindol
UY28342A1 (es) Nuevos compuestos
CO6390066A2 (es) Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas
UY29767A1 (es) Derivados de benzotiazolonas, procesos para su preparación, composiciones farmacéuticas que los contienen y aplicaciones
UY30559A1 (es) Derivados de morfolino pirimidina, procesos de preparacion, composiciones conteniéndolos y aplicaciones
NI201000003A (es) Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas.
UY30819A1 (es) Derivados de pirazol, composiciones farmacéuticas conteniéndolos, procesos de preparacion y aplicaciones
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
CR11641A (es) Derivados heterociclicos de urea y metodos de uso de los mismos-211
UY27740A1 (es) Nuevos compuestos
UY29002A1 (es) Nuevos derivados de hidantoína, procesos parasu preparación, composiciones farmacéuticas que los contienen y su uso en terapia
UY29087A1 (es) Derivados de adamantilo, composiciones farmaceuticas que los contienen, procesos para su preparacion y uso terapeutico
BRPI0415525A (pt) derivados de imidazola e seu uso como agentes farmacêuticos
UY29003A1 (es) Nuevos derivados de hidantoína, procesos para su preparación, composiciones farmacéuticas que los contienen y su uso en terapia
UY30544A1 (es) Compuestos de pirrolo-piperidina y sales farmacéuticametne aceptables de los mismos, procesos de fabricacion, composiciones y aplicaciones
UY31141A1 (es) Compuestos de piperidina y sus usos
DOP2010000374A (es) Derivados heterociclicos de la urea y sus metodos de empleo
CR11825A (es) Derivados de urea heterociclicos para el tratamiento de infecciones bacterianas
ATE302203T1 (de) Pyrazolopyrimidin- und pyrazolotriazinderivate und diese enthaltende pharmazeutische zubereitungen

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150602